Get startedLog in
    Picture of TPG logo

    TPG — TPG News Story

    0.000.00%
    us flag iconLast trade - 00:00
    FinancialsBalancedLarge CapHigh Flyer
    All News

    Brief: Sling Therapeutics Closes $123 Million Series C Financing Led By Forbion

    Picture of TPG logoTPG
    16/09/2026 12:00
    BRIEF-Sling Therapeutics Closes $123 Million Series C Financing Led By Forbion
    Sept 16 (Reuters) - Sling Therapeutics:
    • SLING THERAPEUTICS: FIRST PATIENTS DOSED IN GLOBAL PHASE 3 ORBIT PIVOTAL TRIAL OF LINSITINIB FOR THYROID EYE DISEASE
    • SLING THERAPEUTICS: CLOSES $123 MILLION SERIES C FINANCING LED BY FORBION, PARTICIPATION FROM TPG LIFE SCIENCES INNOVATIONS & ​​SECTORAL ASSET MANAGEMENT
    • SLING THERAPEUTICS: FINANCING TO ADVANCE PHASE 3 DEVELOPMENT OF LINSITINIB FOR THYROID EYE DISEASE
    • SLING THERAPEUTICS: IN CONJUNCTION WITH FINANCING, REGINA SALVAT & FRANÇOIS BEAUBIEN APPOINTED TO CO'S BOARD
    Further company coverage: TPG.O

     ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on TPG

    See all news